Universität zu Köln

Cornely, Oliver A., Gachot, Bertrand, Akan, Hamdi, Bassetti, Matteo, Uzun, Omrun, Kibbler, Christopher, Marchetti, Oscar, de Burghgraeve, Peter, Ramadan, Safaa, Pylkkanen, Liisa, Ameye, Lieveke, Paesmans, Marianne and Donnelly, Peter J. (2015). Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). Clin. Infect. Dis., 61 (3). S. 324 - 332. CARY: OXFORD UNIV PRESS INC. ISSN 1537-6591

Full text not available from this repository.

Abstract

Background. Anti-cancer treatment and the cancer population have evolved since the last European Organisation for Research and Treatment of Cancer (EORTC) fungemia survey, and there are few recent large epidemiological studies. Methods. This was a prospective cohort study including 145 030 admissions of patients with cancer from 13 EORTC centers. Incidence, clinical characteristics, and outcome of fungemia were analyzed. Results. Fungemia occurred in 333 (0.23%; 95% confidence interval [CI], .21-.26) patients, ranging from 0.15% in patients with solid tumors to 1.55% in hematopoietic stem cell transplantation recipients. In 297 evaluable patients age ranged from 17 to 88 years (median 56 years), 144 (48%) patients were female, 165 (56%) had solid tumors, and 140 (47%) had hematological malignancies. Fungemia including polymicrobial infection was due to: Candida spp. in 267 (90%), C. albicans in 128 (48%), and other Candida spp. in 145 (54%) patients. Favorable overall response was achieved in 113 (46.5%) patients by week 2. After 4 weeks, the survival rate was 64% (95% CI, 59%-70%) and was not significantly different between Candida spp. Multivariable logistic regression identified baseline septic shock (odds ratio [OR] 3.04, 95% CI, 1.22-7.58) and tachypnoea as poor prognostic factors (OR 2.95, 95% CI, 1.66-5.24), while antifungal prophylaxis prior to fungemia (OR 0.20, 95% CI, .06-.62) and remission of underlying cancer (OR, 0.18; 95% CI, .06-.50) were protective. Conclusions. Fungemia, mostly due to Candida spp., was rare in cancer patients from EORTC centers but was associated with substantial mortality. Antifungal prophylaxis and remission of cancer predicted better survival.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Cornely, Oliver A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Gachot, Bertrand UNSPECIFIED UNSPECIFIED UNSPECIFIED Akan, Hamdi UNSPECIFIED UNSPECIFIED UNSPECIFIED Bassetti, Matteo UNSPECIFIED UNSPECIFIED UNSPECIFIED Uzun, Omrun UNSPECIFIED UNSPECIFIED UNSPECIFIED Kibbler, Christopher UNSPECIFIED UNSPECIFIED UNSPECIFIED Marchetti, Oscar UNSPECIFIED UNSPECIFIED UNSPECIFIED de Burghgraeve, Peter UNSPECIFIED UNSPECIFIED UNSPECIFIED Ramadan, Safaa UNSPECIFIED UNSPECIFIED UNSPECIFIED Pylkkanen, Liisa UNSPECIFIED UNSPECIFIED UNSPECIFIED Ameye, Lieveke UNSPECIFIED UNSPECIFIED UNSPECIFIED Paesmans, Marianne UNSPECIFIED UNSPECIFIED UNSPECIFIED Donnelly, Peter J. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-398001
DOI:	10.1093/cid/civ293
Journal or Publication Title:	Clin. Infect. Dis.
Volume:	61
Number:	3
Page Range:	S. 324 - 332
Date:	2015
Publisher:	OXFORD UNIV PRESS INC
Place of Publication:	CARY
ISSN:	1537-6591
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language INVASIVE FUNGAL-INFECTIONS; ESCMID-ASTERISK GUIDELINE; LIPOSOMAL AMPHOTERICIN-B; BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; CELL TRANSPLANTATION; CLINICAL-PRACTICE; FLUCONAZOLE; CANDIDIASIS; PROPHYLAXIS Multiple languages Immunology; Infectious Diseases; Microbiology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/39800